Evidence map›Paper›PMID 33953446›Full record

ArticleBulletin of the World Health Organization2021

Eliminating mother-to-child transmission of human immunodeficiency virus, syphilis and hepatitis B in sub-Saharan Africa.

Jennifer Cohn, Morkor N Owiredu, Melanie M Taylor, Philippa Easterbrook, Olufunmilayo Lesi, Bigirimana Francoise, Laura N Broyles, Angela Mushavi, Judith Van Holten, Catherine Ngugi and 12 more

Open access · diamondAbstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 5 countries.

Jennifer CohnUniversity of Pennsylvania School of Medicine, Division of Infectious Diseases, 3400 Spruce St, Philadelphia, PA 19104, United States of America (USA).
Morkor N OwireduGlobal HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
Melanie M TaylorGlobal HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
Philippa EasterbrookGlobal HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
Olufunmilayo LesiWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of the Congo.
Bigirimana FrancoiseWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of the Congo.
Laura N BroylesGlobal Health Impact Group, Atlanta, USA.
Angela MushaviMinistry of Health of Zimbabwe, Harare, Zimbabwe.
Judith Van HoltenGlobal HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
Catherine NgugiMinistry of Health of Kenya, Nairobi, Kenya.
Fuqiang CuiGlobal HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
Dalila ZacharyThe Global Fund, Geneva, Switzerland.
Sirak HailuDepartment of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Windhoek, Namibia.
Fatima TsiourisICAP at Columbia University, New York, USA.
Monique AnderssonDivision of Medical Virology, Stellenbosch University, Tygerberg, South Africa.
Dorothy Mbori-NgachaHIV Section, United Nations Children's Fund, New York, USA.
Wame JallowInternational Treatment Preparedness Coalition, Gaborone, Botswana.
Shaffiq EssajeeHIV Section, United Nations Children's Fund, New York, USA.
Anna L RossScience Division, World Health Organization, Geneva, Switzerland.
Rebecca BaileyElizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Jesal ShahUniversity of Pennsylvania School of Medicine, Division of Infectious Diseases, 3400 Spruce St, Philadelphia, PA 19104, United States of America (USA).
Meg M DohertyGlobal HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
World Health Organization · CHWorld Health Organization Regional Office for Africa · CGGlobal Fund to Fight AIDS, Tuberculosis and Malaria · CHICAP Global HealthMinistry of Health and Child Welfare · ZWStellenbosch University · ZA

Funding

World Health Organization 001
6 · The paper itself

Abstract

Triple elimination is an initiative supporting the elimination of mother-to-child transmission of three diseases - human immunodeficiency virus (HIV) infection, syphilis and hepatitis B. Significant progress towards triple elimination has been made in some regions, but progress has been slow in sub-Saharan Africa, the region with the highest burden of these diseases. The shared features of the three diseases, including their epidemiology, disease interactions and core interventions for tackling them, enable an integrated health-systems approach for elimination of mother-to-child transmission. Current barriers to triple elimination in sub-Saharan Africa include a lack of policies, strategies and resources to support the uptake of well established preventive and treatment interventions. While much can be achieved with existing tools, the development of new products and models of care, as well as a prioritized research agenda, are needed to accelerate progress on triple elimination in sub-Saharan Africa. In this paper we aim to show that health systems working together with communities in sub-Saharan Africa could deliver rapid and sustainable results towards the elimination of mother-to-child transmission of all three diseases. However, stronger political support, expansion of evidence-based interventions and better use of funding streams are needed to improve efficiency and build on the successes in prevention of mother-to-child transmission of HIV. Triple elimination is a strategic opportunity to reduce the morbidity and mortality from HIV infection, syphilis and hepatitis B for mothers and their infants within the context of universal health coverage.

Indexed as

Hepatitis BHIV InfectionsSyphilisAfrica South of the SaharaFemaleHIVHumansInfantInfectious Disease Transmission, Vertical

Identifiers

PMID33953446
PMCPMC8085625
OpenAlexW3148848729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.